Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, HIMS & HERS HEALTH, INC. reported revenue of $2.35B, up 59.0% year over year. Operating margin was 4.5% and net margin 5.5%, on a free-cash-flow margin of 2.4% with capital expenditure at 10.3% of revenue. Every figure is computed directly from HIMS's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $2.35B | 4.5% | 5.5% |
| FY2024 | $1.48B | 4.2% | 8.5% |
| FY2023 | $872M | -3.4% | -2.7% |
| FY2022 | $527M | -13.0% | -12.5% |
| FY2021 | $272M | -42.3% | -39.6% |
How does HIMS compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AACG · ABSI · ACCS · ACHC · ACM · ADUS
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.